Biomaterials Market is Expected to Reach $139 Billion, Globally by 2022

The global biometric market is expected to reach $139 billion by 2022, from $62 billion in 2015, growing at a CAGR of 11.8% from 2016 to 2022, according to Allied Market Research. Metallic biomaterials segment is expected to contribute significantly to the global market revenue until 2022. North America held the leading position in the global market in 2015, and is expected to maintain its lead throughout the study period.

Get access to full summary @: https://www.alliedmarketresearch.com/biomaterials-market

Metallic biomaterials segment contributed the highest revenue share to the global market, owing to highly used in orthopedic treatments for bone support and replacement, due to their strength and resistance to fatigue degradation. Polymeric biomaterials segment is projected to grow at a CAGR of 13.0% from 2016 to 2022, due to increasing demand for biodegradable products, and their use in various applications due their unique features such as flexibility, lightweight, remarkable biocompatibility, and physical & mechanical properties.

Orthopedic disorder was the leading application segment in the market, followed by cardiovascular disorders and drug-delivery systems segments, cumulatively contributing about three-fourths shares of the global market. This was attributed to the high incidence of conditions characterized by degenerative symptoms and notable relief offered by the use of biomaterial-based products. Neurological disorder is an another key application area of the biomaterials market, and is expected to offer lucrative investment opportunities to market players in the near future. However, tissue engineering is projected to be the fastest growing segment due to the introduction of scaffolds, which is one of the biomaterials used in 3D printing.

Request for sample copy of this report at: https://goo.gl/yfXDfn

Key Findings of the Biomaterials Market
In 2015, metallic biomaterials segment contributed significantly to the revenue of the global market, and is projected to maintain this trend during the forecast period.
Among biomaterials, polymeric biomaterial segment is projected to grow rapidly registering a CAGR of 13.0% from 2016 to 2022.
Tissue engineering is projected to be the fastest growing application segment of biomaterials market with CAGR of 35.6% during analysis period.
North America is the leading region in the global biomaterials market.
North America and Europe jointly contributed over three-fourths share of the overall revenue in 2015.
Asia-Pacific biomaterials market is expected to be the fastest growing region during study period.
Chinese biomaterials market is expected to grow at a significant CAGR of 18.5% from 2016 to 2022.

In 2015, North America accounted for significant revenue share in the global biomaterials market, and is expected to maintain this trend throughout the forecast period. This is attributed to increase in prevalence of chronic and degenerative diseases coupled with growth in geriatric population, advent of innovative technologies, heavy funding by government agencies for R&D activities, and growing need to improve quality of life in North America. However, Asia-Pacific is expected to be the fastest growing region throughout 2022, owing to the presence of ample growth opportunities in terms of unmet medical needs for the treatment of cardiovascular, neurological & orthopedic disorders, increasing awareness about biomaterials advantages, and rising acceptance of advanced technologies in this region.

The key players in this market have adopted product development & launch as their key strategies to cater to the changing needs of the industry. Furthermore, companies have collaborated with other key players to develop cost-effective and technologically efficient technologies to strengthen their market positions. The development of novel products with innovative technologies and acquisition of companies possessing innovative technologies are the top strategies adopted by leading players in the market. The key players profiled in this report include Royal DSM, Wright Medical Group N.V., Corbion N.V., Zimmer Biomet Holdings, Inc., Bayer AG, Carpenter Technology Corporation, Covalon Technologies Ltd., Evonik Industries AG, BASF SE, Victrex plc., and Collagen Matrix, Inc.

Allied Market Research is a global market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Our market research department starts with the research task considering specific concerns and ambitions of the client. We understand that every market is driven by certain key factors locally as well as globally. Our analysts dig out those factors, helping clients understand the importance and impact of every such driving force. Moreover, possible restraints of the market are discovered and suggestions to tackle those restraints are formulated after extensive research and analysis of the overall market conditions. Making an even deeper insight, we analyze the market trend including both qualitative and quantitative present market scenario in every geographical region segmented as per the business domain concerned and overall performance in different regions throughout the globe.

5933 NE Win Sivers Drive,
#205, Portland, OR 97220,
United States.
Int'l: +1-503-894-6022
help@alliedmarketresearch.com

This release was published on openPR.